Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.3.1241

Cinobufacin Suppresses Cell Proliferation via miR-494 in BGC-823 Gastric Cancer Cells  

Zhou, Rong-Ping (First College of Clinical Medicine, Nanjing University of Chinese Medicine)
Chen, Gang (Department of Oncology, the Affiliated Jiangning Hospital of Nanjing Medical University)
Shen, Zhi-Li (Department of Oncology, the Affiliated Jiangning Hospital of Nanjing Medical University)
Pan, Li-Qun (First College of Clinical Medicine, Nanjing University of Chinese Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1241-1245 More about this Journal
Abstract
Cinobufacin is used clinically to treat patients with many solid malignant tumors. However, the mechanisms underlying action remain to be detailed. Our study focused on miRNAs involved in cinobufacin inhibition of GC cell proliferation. miRNA microarray analysis and real time PCR identified miR-494 as a significant cinobufacin-associated miRNA. In vivo, ectopic expression of miR-494 inhibited the proliferation and induced apoptosis of BGC-823 cells on CCK-8 and flow cytometry analysis. Further study verified BAG-1 (anti-apoptosis gene) to bea target of miR-494 by luciferase reporter assay and Western blotting. In summary, our study demonstrated that cinobufacin may inhibit the proliferation and promote the apoptosis of BGC-823 cells. Cinobufacin-associated miR-494 may indirectly be involved in cell proliferation and apoptosis by targeting BAG-1, pointing to use as a potential molecular target of cinobufacin in gastric cancer therapy.
Keywords
Cinobufacin; miR-494; BAG-1; gastric cancer; proliferation;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Zhang QW, Liu L, Chen R, et al (2012). Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 13, 2903-8.   과학기술학회마을   DOI   ScienceOn
2 Tie J, Pan Y, Zhao L, et al (2010). MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet, 6, e1000879.   DOI   ScienceOn
3 Zhai XF, Chen Z, Li B, et al (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Integr Med, 2, 90-100.
4 Qi FH, Li AY, Inagaki Y, et al (2010). Antitumor activity of extracts and compoundsfrom the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol, 11, 342-9.
5 Kim WK, Park M, Kim YK, et al (2011) MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res, 17, 7584-94.   DOI
6 Li LN, Zhou X, Gu Y, et al (2013). Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 4107-13.   과학기술학회마을   DOI   ScienceOn
7 Liu Y, Lai L, Chen Q, Song Y, et al (2012). MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. Immunol, 188, 5500-10.   DOI
8 Robertus JL, Kluiver J, Weggemans C, et al (2010). MiRNA pro filing in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol, 149, 896-9.   DOI
9 Romano G, Acunzo M, Garofalo M, et al (2012). MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl, 109, 16570-5.   DOI
10 Sassen S, Miska EA, Caldas C (2008). MicroRNA: implications for cancer. Virchows Arch, 452, 1-10.
11 Takayama S, Sato T, Krajewski S, et al (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-84.   DOI   ScienceOn
12 Du Y, Xu Y, Ding L, et al (2009). Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. Gastroenterol, 44, 556-61.   DOI
13 Chang SS, Jiang WW, Smith I, et al (.2008). MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer, 123, 2791-7.   DOI   ScienceOn
14 Darakhshan S, Bidmeshkipour A, Khazaei M, et al (.2013). Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev, 14, 6869-74.   과학기술학회마을   DOI   ScienceOn
15 Hassan ZK, Daghestani MH (2012). Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line. Asian Pac J Cancer Prev, 13, 3259-64.   과학기술학회마을   DOI   ScienceOn
16 Ding L, Xu Y, Zhang W, et al (2010). MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res, 20, 784-93.   DOI   ScienceOn
17 Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.   DOI   ScienceOn
18 Guo X, Guo L, Ji J, et al (2010). miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun, 398, 1-6.   DOI   ScienceOn
19 Han KQ, Huang G, Gu W, et al (2007). Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol, 13, 3374-9.
20 Han HB, Chen JY, Yuan Y, et al (2008). Cinobufacin-induced apoptosis in human gastric carcinoma cell line BGC-823. Bull Chin Cancer, 17, 233-5.
21 Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Clin Oncol, 24, 2137-50.   DOI   ScienceOn
22 Akdeniz O, Akduman D, Haksever M, et al (2013). Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin. Asian Pac J Cancer Prev, 14, 5301-10.   과학기술학회마을   DOI   ScienceOn
23 Asuthkar S, Velpula KK, Nalla AK, et al (2013). Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells. Oncogene.
24 Wang HJ, Ruan HJ, He XJ, et al (2010). MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer, 46, 2295-303.   DOI   ScienceOn
25 Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, andfunction. Cell, 116, 281- 97.   DOI   ScienceOn